Articles Archives - Page 341 of 733

MondayNov 29, 2021 9:30 am

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

Market analysts place high hopes on the potential of the United Kingdom market Growing demand from patients and patient families brought the country’s medical cannabis program to a tipping point RYAH is committed to providing valuable insight and transforming patient care through big data and artificial intelligence After three years of medical cannabis being legal in the United Kingdom, the country has a total of only three patients with a prescription in the entire public system, noted a recent blog from RYAH Group (CSE: RYAH). The article noted that many more patients receive cannabis-derived medications, including flower and cannabis oil,…

MondayNov 29, 2021 9:30 am

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Marketing Reach, Offers Discounts, Through New Subscription Service

Plant-based food consumers are a growing market sector, increasing their purchases at a rate almost 2.5 times the growth of the overall foods market during the past two years Plant-based community brand builder PlantX Life Inc. is becoming a growing global presence as part of its efforts to become a one-stop shopping source of products and information about the plant-based lifestyle PlantX has physical store presence in Canada and the U.S., as well as one in Israel that will open before the end of the year The company’s e-commerce platform recently added a subscription service that caters to recurring customer…

MondayNov 29, 2021 9:00 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psilocybin Drug Program for the Treatment of Pain and Eating Disorders Takes On Special Meaning Leading Up To The Holidays

People with eating disorders know all about the difficulties faced during holiday celebrations and their association with heavy eating The fall-winter holiday season can also adversely affect people suffering from certain chronic pains, as temperatures and pressure changes can increase pain sensitivity Tryp is looking to help alleviate problems associated with eating disorders and chronic pain through its psilocybin-based drug program that focuses on conditions with high unmet needs The company has submitted several IND applications for Phase 2a studies evaluating TRP-8802’s effectiveness in patients with chronic pain and select eating disorders There is no denying that food is a…

MondayNov 29, 2021 9:00 am

Insurtech Market Seen as a Major Driver for Big Data and Mobile Tech Innovator FingerMotion Inc. (FNGR)

U.S.-based FingerMotion is a technology innovator focused on smart communication applications in China’s mobile-hungry billion-plus population The company’s big data services are relatively new in development but already play a significant role in the insurtech industry’s global growth trends While most of FingerMotion’s revenues are derived from its SMS and MMS products, executives anticipate its big data services will eventually be the company’s largest driver of profits The insurtech industry has already generated record annual deal-making this year as of the third quarter, outpacing all of 2020 by 48 percent The insurtech industry has turned 2021 into a record year…

MondayNov 29, 2021 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

InMed Pharmaceuticals released Q1 2022 financial results in which it reported a year-on-year increase in research and development expenses primarily due to increased activities related to INM-755 clinical trials The company’s cash, cash equivalents, and short-term investments also grew quarter over quarter from $7.4 million to $15.4 million Following the closing of BayMedica’s acquisition, the integrated teams are working together with a focus on launching selected rare cannabinoids, growing revenue, and expanding sales InMed has commenced Phase 2 clinical trial of INM-755 (cannabinol) cream for the treatment of a group of rare skin disorders Preclinical data of INM-088, the company’s…

WednesdayNov 24, 2021 12:17 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Looking to Change Narrative in Treating Fibromyalgia, Chronic Pain

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is looking to transform the existing treatment of fibromyalgia, along with other forms of chronic pain, and relieve the suffering of millions of patients. To achieve this, the company is relying on the guidance of its scientific advisory board (“SAB”) as well as research-based work conducted in partnership with the University of Michigan (“U-M”). “According to Tryp’s internal analysis, over 4 million people suffer from fibromyalgia in the United States. Globally, the condition affects an estimated 3-6% of the population (roughly 232-465 million people). Unfortunately, despite the disease afflicting millions, researchers have not yet…

WednesdayNov 24, 2021 8:30 am

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Produces Raw Materials for Numerous Clean-Energy, Advanced Technologies

An ever-increasing demand for energy is fueling the focus on sustainable energy solutions. UUUU is proud to produce the raw materials that make numerous clean-energy and advanced technologies possible. Energy Fuels began producing rare earths in 2021, which are used in electric vehicles, renewable energy, batteries and other technologies. As the world becomes more focused on and committed to clean energy and sustainability, companies in every sector are recognizing the importance of advancing ESG (environmental, sustainability, and governance) priorities. A leading U.S.-based uranium mining company Energy Fuels (NYSE American: UUUU) (TSX: EFR) places a high priority on its efforts to…

WednesdayNov 24, 2021 8:30 am

DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Offers AI Solution to Improve Company Workforce, Brand and Culture

Hiring the wrong individual or placing a good candidate on the wrong team holds dire consequences for organizations. PPI evaluates, improves a company’s workforce, brand and culture by revealing the personality traits and sentiment buried in human expression. With PPI, savvy organizations can make better hiring decisions, reduce employment attrition and improve workplace culture. Hiring the right talent and personality for a job is vital for employees — and employers — to be engaged and happy in the workplace, yet it can be hard to know when the person and position are perfect for each other. According to a Forbes article,…

WednesdayNov 24, 2021 8:30 am

StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Exploration and Expansion Program, A 2021 Outlook

StraightUp marked 2021 with strategic opportunities in the United States and Peru These projects were selected by management based on past exploration and proven reserves in these regions 2021 also marked the year StraightUp up-listed to the OTCQB Venture Market in the United States StraightUp is optimistic about 2022 For the 2021 fiscal and calendar year, StraightUp Resources (CSE: ST) (OTCQB: STUPF) set out on an aggressive asset acquisition plan, coupled with an exploration program that would be the highlight of the year. Thus far, it has acquired the West Cat Mine in Nevada, along with the Ferdinand Gold Project…

WednesdayNov 24, 2021 8:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Drug Delivery Technology Finding Multiple Medical Applications

Lexaria intends to undertake its most ambitious study yet – HYPER-H21-4 – as it pursues regulatory approval for DehydraTECH-CBD for potential use as a treatment for hypertension HYPER-H21-4 will build on successes witnessed in initial human hypertension studies The company, which has a fully funded R&D budget, recently announced new R&D programs covering multiple conditions, including dementia, diabetes, and rheumatoid disease Lexaria is committed to improving lives and lessening deaths through its patented DehydraTECH(TM) technology With a fully-funded research and development (“R&D”) budget, Lexaria Bioscience (NASDAQ: LEXX), a global leader in enhancing the speed, efficacy, bioavailability, and brain absorption of…

Site Search

Company Search

Category: Articles

RYAH Group Inc. (CSE: RYAH) Releases Overview of UK Cannabis Market

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Expands Marketing Reach, Offers Discounts, Through New Subscription Service

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Psilocybin Drug Program for the Treatment of Pain and Eating Disorders Takes On Special Meaning Leading Up To The Holidays

Insurtech Market Seen as a Major Driver for Big Data and Mobile Tech Innovator FingerMotion Inc. (FNGR)

InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2022 Financial Results, Business Update Showing Positive Momentum Across All Its Programs

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Looking to Change Narrative in Treating Fibromyalgia, Chronic Pain

Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Produces Raw Materials for Numerous Clean-Energy, Advanced Technologies

DigiMax Global Inc. (CSE: DIGI) (OTC: DBKSF) Offers AI Solution to Improve Company Workforce, Brand and Culture

StraightUp Resources Inc.’s (CSE: ST) (OTCQB: STUPF) Exploration and Expansion Program, A 2021 Outlook

Lexaria Bioscience Corp. (NASDAQ: LEXX) DehydraTECH(TM) Drug Delivery Technology Finding Multiple Medical Applications

Market Basics

Newsletter Publishers

Public Companies